GD1bCer (d20:1/20:0) is a substance consisting of glycosphingolipid and sialic acid, which can be used in the research of the pathogenesis of neurodegenerative diseases.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.